Legal & General Group PLC Lexicon Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 11,466 shares of LXRX stock, worth $18,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,466
Previous 8,212 39.62%
Holding current value
$18,001
Previous $19,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.54 - $2.28 $5,011 - $7,419
3,254 Added 39.62%
11,466 $19,000
Q1 2024

May 14, 2024
SELL
$1.3 - $3.58 $3,829 - $10,546
-2,946 Reduced 26.4%
8,212 $19,000
Q4 2023

Feb 15, 2024
SELL
$1.0 - $1.53 $72,477 - $110,889
-72,477 Reduced 86.66%
11,158 $17,000
Q3 2023

Nov 14, 2023
SELL
$1.06 - $2.33 $21,142 - $46,474
-19,946 Reduced 19.26%
83,635 $91,000
Q2 2023

Aug 14, 2023
BUY
$2.15 - $3.49 $158,078 - $256,602
73,525 Added 244.63%
103,581 $237,000
Q1 2023

May 15, 2023
BUY
$1.99 - $2.68 $6,771 - $9,120
3,403 Added 12.77%
30,056 $73,000
Q3 2022

Nov 14, 2022
BUY
$1.94 - $3.43 $15,141 - $26,771
7,805 Added 41.41%
26,653 $64,000
Q2 2022

Aug 22, 2022
BUY
$1.31 - $2.69 $1,679 - $3,448
1,282 Added 7.3%
18,848 $35,000
Q3 2021

Nov 15, 2021
BUY
$3.38 - $5.35 $38,572 - $61,054
11,412 Added 185.44%
17,566 $84,000
Q2 2021

Aug 12, 2021
BUY
$4.12 - $5.87 $2,867 - $4,085
696 Added 12.75%
6,154 $28,000
Q1 2021

May 17, 2021
BUY
$3.45 - $9.09 $1,438 - $3,790
417 Added 8.27%
5,458 $32,000
Q3 2020

Nov 13, 2020
SELL
$1.44 - $2.1 $2,717 - $3,962
-1,887 Reduced 27.24%
5,041 $7,000
Q2 2020

Aug 14, 2020
SELL
$1.75 - $2.3 $813 - $1,069
-465 Reduced 6.29%
6,928 $14,000
Q1 2020

May 14, 2020
SELL
$1.8 - $4.28 $17,319 - $41,182
-9,622 Reduced 56.55%
7,393 $15,000
Q4 2019

Feb 13, 2020
BUY
$3.16 - $5.15 $4,645 - $7,570
1,470 Added 9.46%
17,015 $71,000
Q4 2018

Feb 15, 2019
BUY
$6.15 - $10.51 $5,319 - $9,091
865 Added 5.89%
15,545 $103,000
Q2 2018

Aug 10, 2018
SELL
$7.8 - $13.69 $9,430 - $16,551
-1,209 Reduced 7.61%
14,680 $176,000
Q1 2018

May 17, 2018
SELL
$7.86 - $11.39 $29,946 - $43,395
-3,810 Reduced 19.34%
15,889 $136,000
Q4 2017

Feb 13, 2018
BUY
$8.77 - $12.28 $172,760 - $241,903
19,699
19,699 $197,000

Others Institutions Holding LXRX

# of Institutions
131
Shares Held
240M
Call Options Held
617K
Put Options Held
286K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $296M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email